TechNation Radio Podcast

On this week’s Tech Nation, NYU marketing professor, Adam Alter about the rise of addictive personal technology. Then on Tech Nation Health, chief correspondent, Daniel Kraft, talks about the cutting edge of stem cell therapies today and in the future, and Second Genome’s Dr. Karim Dabbagh links bacteria in the gut to the inflammation experienced in IBD, Irritable Bowel Disease.

On this week’s Tech Nation, former Google CEO and Alphabet Executive Chair, Eric Schmidt along with former Senior Vice President for Products, Jonathan Rosenberg talk about “How Google Works”. Then on Tech Nation Health, faster diagnostics for the 25 species of bacteria which cause Sepsis. John McDonough, the CEO of T2 Biosystems, talks about their efforts in Sepsis and other new diagnostics for candida and Lyme disease.

On this week’s Tech Nation, former Google CEO and Alphabet Executive Chair, Eric Schmidt along with former Senior Vice President for Products, Jonathan Rosenberg talk about “How Google Works”. Then on Tech Nation Health, faster diagnostics for the 25 species of bacteria which cause Sepsis. John McDonough, the CEO of T2 Biosystems, talks about their efforts in Sepsis and other new diagnostics for candida and Lyme disease.

On this week’s Tech Nation, a Special Edition of Tech Nation Health, where the NFL and Major League Baseball both figure in. First up is Jim Joyce, CEO of Aethlon Medical and Executive Chairman of Exosome Sciences. Its blood test appears to identify CTE – Chronic Traumatic Encephalopathy – in retired NFL players. Then Right Eye returns with improvements to its eye tracking diagnostics for medical conditions, and a new project with professional sports. Barbara Barclay is the President of Right Eye, and Dr. Melissa Hunfalvay is its Chief Scientific Officer. Then, Tech Nation Health’s chief correspondent, Dr. Daniel Kraft, talks about disruption in medical care, all brought about by emerging technology.

On this week’s Tech Nation, a Special Edition of Tech Nation Health, where the NFL and Major League Baseball both figure in. First up is Jim Joyce, CEO of Aethlon Medical and Executive Chairman of Exosome Sciences. Its blood test appears to identify CTE – Chronic Traumatic Encephalopathy – in retired NFL players. Then Right Eye returns with improvements to its eye tracking diagnostics for medical conditions, and a new project with professional sports. Barbara Barclay is the President of Right Eye, and Dr. Melissa Hunfalvay is its Chief Scientific Officer. Then, Tech Nation Health’s chief correspondent, Dr. Daniel Kraft, talks about disruption in medical care, all brought about by emerging technology.

On this week’s Tech Nation, Olivia Fox Cabane and Judah Pollack with “The Net and the Butterfly – The Art and Practice of Breakthrough Thinking” – their exercises all source from breakthroughs in neuroscience. Then on Tech Nation Health, Dr. Daniel Kraft talks about the future of Neuroscience and Neuromedicine, and on BioTech Nation, Dr. Asha Das from Tocagen talks about their approach to treating brain tumors –it starts with a virus.

On this week’s Tech Nation, Olivia Fox Cabane and Judah Pollack with “The Net and the Butterfly – The Art and Practice of Breakthrough Thinking” – their exercises all source from breakthroughs in neuroscience. Then on Tech Nation Health, Dr. Daniel Kraft talks about the future of Neuroscience and Neuromedicine, and on BioTech Nation, Dr. Asha Das from Tocagen talks about their approach to treating brain tumors –it starts with a virus.

On this week’s Tech Nation, it’s the second of a two-part series on Digital Health. On this show, Moira speaks with DR. RAJAIE BATNIJI, the Co-Founder & Chief Health Officer of Collective Health. It all started with a nightmare in filing health claims. Then on BioTech Nation, RIF PAMUKCHU, the CEO of RxMP Therapeutics. It’s about the technology of stopping blood loss.

On this week’s Tech Nation, it’s the second of a two-part series on Digital Health. On this show, Moira speaks with DR. RAJAIE BATNIJI, the Co-Founder & Chief Health Officer of Collective Health. It all started with a nightmare in filing health claims. Then on BioTech Nation, RIF PAMUKCHU, the CEO of RxMP Therapeutics. It’s about the technology of stopping blood loss.

On this week’s Tech Nation, Moira speaks with Steven Johnson, the Author, “Wonderland: How Play Made the Modern World.” Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft talks about the future of cancer – its prevention, early detection and emergent treatments. And Dr. Niclas Stiernholm, the President & CEO of Trillium Therapeutics, tells us about identifying cancer cells so that the immune system can remove them.

On this week’s Tech Nation, Moira speaks with Steven Johnson, the Author, “Wonderland: How Play Made the Modern World.” Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft talks about the future of cancer – its prevention, early detection and emergent treatments. And Dr. Niclas Stiernholm, the President & CEO of Trillium Therapeutics, tells us about identifying cancer cells so that the immune system can remove them.

On this week’s Tech Nation, Moira speaks with DEREK THOMPSON, a Senior Editor at The Atlantic, about his book “Hit Makers: The Science of Popularity in the Age of Distraction”. Then on Tech Nation Health, Chief Correspondent Dr. DANIEL KRAFT talks about the future of aging, longevity and technology in the near and more distant future, and on BioTech Nation, Dr. NATHANIEL DAVID, Founder & CEO of Unity Biotechnology talks about the role of “senescent” cells in aging.

On this week’s Tech Nation, Moira speaks with DEREK THOMPSON, a Senior Editor at The Atlantic, about his book “Hit Makers: The Science of Popularity in the Age of Distraction”. Then on Tech Nation Health, Chief Correspondent Dr. DANIEL KRAFT talks about the future of aging, longevity and technology in the near and more distant future, and on BioTech Nation, Dr. NATHANIEL DAVID, Founder & CEO of Unity Biotechnology talks about the role of “senescent” cells in aging.

On this week’s Tech Nation, Moira speaks with ALAN BURDICK, former senior editor at The New Yorker and National Book Award finalist, about his latest book: “Why Time Flies: A Mostly Scientific Investigation”. Then on Tech Nation Health, Ken Horne, the CEO of SymicBio describes their efforts to better the long term results of angioplasty and a clinical trial for osteoarthritis in the knee. We’ll also hear from our chief correspondent DR. DANIEL KRAFT on the future of medical education. It’s not just doctors and nurses, but it’s also changing for everyday people.

On this week’s Tech Nation, Moira speaks with ALAN BURDICK, former senior editor at The New Yorker and National Book Award finalist, about his latest book: “Why Time Flies: A Mostly Scientific Investigation”. Then on Tech Nation Health, Ken Horne, the CEO of SymicBio describes their efforts to better the long term results of angioplasty and a clinical trial for osteoarthritis in the knee. We’ll also hear from our chief correspondent DR. DANIEL KRAFT on the future of medical education. It’s not just doctors and nurses, but it’s also changing for everyday people.